1. Advanced Hodgkin lymphoma in the east of England cancer network: A 10‐year comparative analysis of outcomes for ABVD and escalated‐BEACOPP treated patients aged 16 to 59. (June 2017) Authors: Russell, J.; Collins, A.; Fowler, A.; Karanth, M.; Saha, C.; Shyamsundar, V.; Docherty, S.; Kirkwood, A.; Maw, K.; Cooke, L.; Hodson, A.; Shah, N.; Sadullah, S.; Grigoropoulos, N.; Uttenthal, B.; Follows, G. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 318 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. POLATUZUMAB VEDOTIN WITH BENDAMUSTINE AND RITUXIMAB FOR RELAPSED/REFRACTORY HIGH‐GRADE B‐CELL LYMPHOMA: THE UK EXPERIENCE. (17th June 2021) Authors: Northend, M.; Wilson, W.; Osborne, W.; Fox, C. P.; Davies, A. J; El‐Sharkawi, D.; Phillips, E. H.; Sim, H. W.; Sadullah, S.; Shah, N.; Peng, Y. Y.; Qureshi, I.; Addada, J.; Mora, R. F.; Phillips, N.; Kuhnl, A.; Davies, E.; Wrench, D.; McKay, P.; Karpha, I. Journal: Hematological oncology Issue: Volume 39(2021)Supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗